These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26391933)

  • 1. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD; McCavit TL
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do children with sickle cell disease receive disparate care for pain in the emergency department?
    Zempsky WT; Loiselle KA; McKay K; Lee BH; Hagstrom JN; Schechter NL
    J Emerg Med; 2010 Nov; 39(5):691-5. PubMed ID: 19703740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
    Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
    Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
    Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR;
    Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
    Borland M; Jacobs I; King B; O'Brien D
    Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.
    Glassberg J; Simon J; Patel N; Jeong JM; McNamee JJ; Yu G
    Am J Emerg Med; 2015 Oct; 33(10):1396-401. PubMed ID: 26283616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency Department.
    Lin SM; Strouse JJ; Whiteman LN; Anders J; Stewart RW
    Pediatr Emerg Care; 2016 Jan; 32(1):14-6. PubMed ID: 25834959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expedited Delivery of Pain Medication for Long-Bone Fractures Using an Intranasal Fentanyl Clinical Pathway.
    Schacherer NM; Erikson Ramirez D; Frazier SB; Perkins AM
    Pediatr Emerg Care; 2015 Aug; 31(8):560-3. PubMed ID: 25875994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P; Hafner JW; Martinovich Z; Artz N
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective.
    Rees CA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown KM; Casper TC; Chapman LL; Chumpitazi CE; Cohen DM; Dampier C; Ellison AM; Grasemann H; Hatabah D; Hickey RW; Hsu LL; Bakshi N; Leibovich S; Patil P; Powell EC; Richards R; Sarnaik S; Weiner DL; Morris CR;
    Am J Hematol; 2023 Apr; 98(4):620-627. PubMed ID: 36606705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
    Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
    J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
    Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R
    Trials; 2012 May; 13():74. PubMed ID: 22647439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative review of the clinical use of intranasal fentanyl versus morphine in a paediatric emergency department.
    Borland ML; Clark LJ; Esson A
    Emerg Med Australas; 2008 Dec; 20(6):515-20. PubMed ID: 19125831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.